USSTOCK.TODAY
Market Closed
Log in Sign up

Viking Therapeutics to Announce Q3 Results: Focus on Spending and Clinical Progress

Earnings Whispers ·

VKTX
VKTX Viking Therapeutics Inc
$25.84 -2.05%
View chart & analysis →
  1. 1Viking Therapeutics will announce its third-quarter results after the US market closes on October 28.
  2. 2Wall Street expects a third-quarter loss per share of $1.00.
  3. 3This represents an expected 23.5% increase in loss compared to the $0.81 loss per share in the same period last year.

So what's the key point?

Viking Therapeutics will release its third-quarter results on October 28. Experts expect the company to report a loss of $1.00 per share.

Source Earnings Whispers · View original ↗

Related 3-line summaries

Viking Therapeutics initiates Phase 3 clinical trials for oral VK2735 The Motley Fool +1 · 2d agoApple Returns to the $5 Trillion Market Cap Club The Motley Fool +2 · 5d ago3 cheap stocks to consider buying before late 2026 The Motley Fool +1 · Oct 14
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news